Comparison of adaptive immunity between different Salmonella serovers
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1R21AI196078-01
Grant search
Key facts
Disease
Salmonella infectionStart & end year
20262028Known Financial Commitments (USD)
$412,206Funder
National Institutes of Health (NIH)Principal Investigator
STEPHEN MCSORLEYResearch Location
United States of AmericaLead Research Institution
UNIVERSITY OF CALIFORNIA AT DAVISResearch Priority Alignment
N/A
Research Category
N/A
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Project Summary/Abstract Systemic Salmonella infections have three main infectious causes (Typhi, Paratyphi, and a group of non- typhoidal serovars). Although new conjugate vaccines exist for Typhi, there are still no licensed vaccines for Paratyphi or non-typhoidal disease, despite the fact that they account for more than 50% of deaths due to systemic Salmonellosis. Since Typhi and Paratyphi serovars do not infect other animals, most of what we know about adaptive immunity to Salmonella comes from infection of mouse strains with NTS strains. In this application we will use a new mouse model that is permissive for Typhi infection and allows side-by-side analysis of typhoidal and non-typhoidal disease. We propose to, (i) validate this new model by testing whether typhoid strains have delayed T cell and B cell activation in vivo, and (ii) determine whether ViCPS expression allows evasion of adaptive immunity.